1. Cytotoxic cardenolide glycosides of Roupellina (Strophanthus) boivinii from the Madagascar rainforest.
- Author
-
Karkare S, Adou E, Cao S, Brodie P, Miller JS, Andrianjafy NM, Razafitsalama J, Andriantsiferana R, Rasamison VE, and Kingston DG
- Subjects
- Antineoplastic Agents, Phytogenic chemistry, Cardenolides chemistry, Drug Screening Assays, Antitumor, Female, Glycosides chemistry, Humans, Inhibitory Concentration 50, Madagascar, Antineoplastic Agents, Phytogenic isolation & purification, Antineoplastic Agents, Phytogenic pharmacology, Cardenolides isolation & purification, Cardenolides pharmacology, Glycosides isolation & purification, Glycosides pharmacology, Plants, Medicinal chemistry, Strophanthus chemistry
- Abstract
Bioassay-guided fractionation of an ethanol extract of Roupellina (Strophanthus) boivinii from the rainforest of Madagascar afforded the six new cardenolide glycosides boivinides 1-6, as well as the four known cardenolide glycosides digitoxigenin 3-O-[beta-D-glucopyrananosyl-(1-->4)-alpha-L-acofriopyranoside], corotoxigenin 3-O-beta-D-boivinoside, 17alpha-corotoxigenin 3-O-beta-D-sarmentoside, and uzarigenin 3-O-alpha-L-rhamnoside. The structures of these compounds were elucidated by various 1D and 2D NMR techniques. All new compounds showed significant antiproliferative activity against the A2780 human ovarian cancer cell line, with boivinide A being the most active at IC50 = 0.17 microM.
- Published
- 2007
- Full Text
- View/download PDF